Remove Competition Remove Government Remove Healthcare Remove Specialization
article thumbnail

Streamlining Center of Excellence Provider Network Development in Record Time

Clarify Health

With an eye toward curbing healthcare costs while improving quality, many organizations are investing in Centers of Excellence (CoEs). Healthcare Centers of Excellence are recognized for their commitment to quality, expertise, and the pursuit of the best possible outcomes for patients. Feeling inspired?

article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

Bringing an end to a 13-year deliberation on a whistleblower lawsuit, Biogen recently agreed to pay a $900 million settlement , amidst increased government alertness on pharmaceutical fraud. However, new MS drugs like Novartis ’ Gilenya, were going to soon enter the market and increase competition within the MS therapeutic landscape.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Top 10 Clinical Research Companies in the USA

Medico Reach

To bring effective medicines and Innovations in healthcare industry , a Clinical Research Organization or Contract Research Organization (CRO) are a must for the Biotech, Medtech, and pharma industries. In 2022, the global clinical research market stands at $63.6 billion , and by 2027, it is expected to reach around an exciting amount of 115.1

article thumbnail

Career Changes for Nurses: New Opportunities for Your Skills and Experience

Rep-Lite

It offers an array of opportunities in various healthcare settings. They seek fresh challenges that stimulate their intellectual curiosity and provide a new perspective on the healthcare industry. The horizons expand, and new doors open, offering fresh perspectives while playing their role in healthcare facilities.

article thumbnail

You get what you agree to, at least when it comes to the money under VPAS

pharmaphorum

Predictable for government. The 2019 VPAS deal was struck as a negotiation between DHSC, NHS England, the devolved nations, as well as others on the side of the government and industry body, the ABPI. One of those is Celltrion Healthcare, which says that it is no longer viable to continue to supply the NHS with biosimilars.

article thumbnail

Getting Creative with Sustainability | How Pharma Engages

Pharma Marketing Network

Increasing competition for talent, as well as the uncertainty of remote versus in-person workspaces, impacts new hire engagement. And last, but certainly not least—governance. Company policies, like the code of ethical conduct, are examples of governance that typically stem from the corporate level. Why make it inviting?

Pharma 103
article thumbnail

The Top 3 Legal Considerations for Pediatric Digital Health Companies

Nixon Gwilt Law

However, as with any emerging area of healthcare innovation, new legal and regulatory considerations arise that must be thoughtfully addressed. does not currently have centralized insurance coverage for pediatric healthcare. Proper planning can be a competitive edge for your pediatric digital health organization.